Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of enantiomer-kaurenoid diterpene kamebacetal A in preparation of medicine for treating lung cancer

A kind of kaurane diterpenoid, the technology of therapeutic effect, is applied in the field of biomedicine

Inactive Publication Date: 2021-11-09
NORTHWEST NORMAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some compounds of this backbone type can directly target and bind to the taxane site of β-tubulin, which has a significant microtubule stabilizing effect, and are potential microtubule-accelerating drugs (MSAs), which can be used to prepare therapeutic The use of lung cancer drugs has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of enantiomer-kaurenoid diterpene kamebacetal A in preparation of medicine for treating lung cancer
  • Application of enantiomer-kaurenoid diterpene kamebacetal A in preparation of medicine for treating lung cancer
  • Application of enantiomer-kaurenoid diterpene kamebacetal A in preparation of medicine for treating lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1: Kamebacetal A can concentration-dependently inhibit the proliferation of A549 and H1299 cells

[0030] 1.1) MTT method to detect cell proliferation rate

[0031] Take the A549 and H1299 cells in the logarithmic growth phase, and use 6×10 4 Cells / mL were inoculated in a 96-well plate, 100 μL of cell suspension was added to each well, and three parallels were set up in each group. Place at 37°C, 5% CO 2 After 24 hours of adherent culture in the cell culture incubator, add 100 μL of complete medium containing different concentrations of kamebacetal A or the positive control drug paclitaxel, continue to culture for 24 hours, add 20 μL of MTT (5 mg / mL) to each well, and discard the supernatant after incubation for 4 hours , add 150 μL of DMSO, shake for 10 min, detect the OD value of each well at 490 nm with a microplate reader and calculate the cell viability.

[0032] 1.2) Experimental results

[0033] MTT assay found that with the increase of drug concentra...

Embodiment 2

[0034] Example 2: Low concentration of kamebacetal A produces G on A549 and H1299 cells 2 / M phase arrest without causing apoptosis

[0035] 2.1) The effect of kamebacetal A on A549 and H1299 cell cycle detected by flow cytometry

[0036] Take the A549 and H1299 cells in the logarithmic growth phase, and use 6×10 4 Cells / mL were inoculated in a 60mm culture dish. After culturing for 24 hours, different concentrations of kamebacetal A were added to continue culturing for 24 hours. The original medium was discarded and washed three times with PBS (pH7.4). The cells were collected and used Cells were resuspended in pre-cooled PBS (pH 7.4), added with pre-cooled absolute ethanol (final concentration: 70%), and fixed overnight at 4°C. Cells were collected by centrifugation at 1200 rpm, washed with pre-cooled PBS, then added RNaseA (final concentration 50 μg / mL) in a water bath at 37°C for 30 minutes, then added PI (final concentration 50 μg / mL) and incubated at 4°C in the dark fo...

Embodiment 3

[0046] Example 3: Kamebacetal A promotes the assembly and stability of microtubules in A549 and H1299 cells

[0047] 3.1) The effect of kamebacetal A on the microtubule network assembly of A549 and H1299 cells was detected by indirect immunofluorescence technique

[0048] The A549 and H1299 cells in the logarithmic growth phase were taken, and the inoculation and drug addition were the same as described in "2.1)". After culturing the cells for 24 h, add complete medium containing different concentrations of drugs to continue culturing for 24 h, wash with PBS (pH7.4) three times, fix with 4% formaldehyde for 15 min, and then add PBS containing 0.3% Triton X-100 for 30 min to permeate. Add the primary antibody (α-tubulin antibody) and incubate at 37°C for 1 h in a wet box; wash 3 times with PBS (pH7.4), add the secondary antibody and incubate at 37°C in the dark for 1 h in a wet box; then wash with PBS (pH7.4) for 1 h; pH7.4) washed 3 times, mounted (glycerol: PBS = 1: 1), obse...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of enantiomer-kaurenoid diterpene kamebacetal A in preparation of a medicine for treating the lung cancer. The kamebacetal A can be combined with a Taxane site of beta-tubulin, remarkably promotes polymerization of the tubulin under in-vitro conditions and assembly of microtubules in human non-small cell lung cancer A549 and H1299 cells, increases the network density of the microtubules in the cells, interferes dynamic balance of the microtubules in the cells, and enables the cell cycle of proliferated lung cancer cells to be retarded so as to cause cell proliferation inhibition; moreover, the kamebacetal A can resist a low temperature or a depolymerization effect of a microtubule depolymerization drug nocodazole on the microtubules, so that the stability of the microtubules is improved; and experimental results show that the kamebacetal A shows similar pharmacological effects and action mechanisms with an anti-cancer drug paclitaxel, which has important value for research and development of new anti-lung cancer drugs, and also prompts that the compound can be used as a molecular probe to be applied to basic research of a microtube assembly molecular mechanism.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to the application of ent-kaurene diterpene kamebacetal A in the preparation of drugs for treating lung cancer, in particular to the application of ent-kaurene diterpene kamebacetal A in the preparation of targeting microtubules and destroying microtubules Application of anti-lung cancer drugs to inhibit cancer cell division by assembly kinetics. Background technique [0002] Microtubules are one of the most important cytoskeletons in eukaryotes. They play a key role in cell life processes such as maintaining cell shape, cell migration, intracellular material transportation, cell division, and cell signal transduction. Under normal physiological conditions, microtubules are highly dynamic structures that are in a dynamic equilibrium of continuous assembly and disassembly. The mitotic apparatus (spindle) of eukaryotic cells is assembled from microtubules and is critical for proper cell di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/352A61P35/00A61P11/00
CPCA61K31/352A61P35/00A61P11/00
Inventor 丁兰苟冬婵杜世龙朱金辉
Owner NORTHWEST NORMAL UNIVERSITY